# Insys Therapeutics, Inc.

Insys Therapeutics, Inc. is a company headquartered in Phoenix, AZ, United States.

## Company overview

- **Legal name:** Insys Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Phoenix, AZ, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001516479

## About

Insys Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001516479, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2019-03-13, it reported annual revenue of USD 82,080,000; net income of USD -124,507,000; total assets of USD 192,527,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Revenue:** $82.1M (USD 82,080,000)
- **Net income:** -$124.5M (USD -124,507,000)
- **Total assets:** $192.5M (USD 192,527,000)
- **Cash and equivalents:** $31.6M (USD 31,552,000)
- **Operating cash flow:** -$56.0M (USD -55,989,000)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $140.7M (USD 140,693,000)
- **Net income:** -$228.0M (USD -228,015,000)
- **Total assets:** $279.1M (USD 279,080,000)
- **Cash and equivalents:** $32.0M (USD 31,999,000)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $242.3M (USD 242,275,000)
- **Net income:** $7.6M (USD 7,590,000)
- **Total assets:** $356.1M (USD 356,136,000)
- **Cash and equivalents:** $104.6M (USD 104,642,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $330.8M (USD 330,797,000)
- **Net income:** $58.5M (USD 58,476,000)
- **Total assets:** $351.2M (USD 351,196,000)
- **Cash and equivalents:** $79.5M (USD 79,515,000)
- **Operating cash flow:** $100.8M (USD 100,850,000)
- **Later filings:** Net income, Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2020-02-11 — period 2020-02-11 — 8-K
- Form 8-K — filed 2020-02-10 — period 2020-02-05 — 8-K
- Form 8-K — filed 2020-02-05 — period 2020-01-30 — 8-K
- Form 8-K — filed 2020-01-17 — period 2020-01-16 — 8-K
- Form 8-K — filed 2020-01-10 — period 2020-01-06 — 8-K
- Form 8-K — filed 2020-01-06 — period 2019-12-30 — 8-K
- Form 8-K — filed 2019-12-26 — period 2019-12-19 — 8-K
- Form 8-K — filed 2019-12-03 — period 2019-11-26 — 8-K
- Form 8-K — filed 2019-11-20 — period 2019-11-14 — 8-K
- Form SC 13G — filed 2019-11-19 — SCHEDULE 13G
- Form 8-K — filed 2019-11-04 — period 2019-10-31 — 8-K
- Form 8-K — filed 2019-10-25 — period 2019-10-23 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/insys-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology